LanzaTech Global, Inc. (LNZA) Spending and interest coverage
- R&D / revenue · 12 months: Value 47.55%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 8.08%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 47.55% | Research and development expense / revenue. Period ending 2026-06-30. $27.73M ÷ $58.31M × 100 ≈ 47.55% |
| Stock-based compensation / revenue · 12 months | 8.08% | Share-based compensation / revenue. Period ending 2026-06-30. $4.71M ÷ $58.31M × 100 ≈ 8.08% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 27.73M USD | Research and Development Expense |
| Revenue | 58.31M USD | |
| Stock-based compensation | 4.71M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -35.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.73M | $58.31M | $4.71M | $-35.55M | (m) | 47.55% | 8.08% | (m) | (m) |
| 2026-03-31 | $40.70M | $58.38M | $6.25M | $-57.91M | (m) | 69.71% | 10.70% | (m) | (m) |
| 2025-12-31 | $53.18M | $55.84M | $7.20M | $-79.16M | (m) | 95.24% | 12.89% | (m) | (m) |
| 2025-09-30 | $58.14M | $39.88M | $9.38M | $-105.97M | (m) | 145.81% | 23.53% | (m) | (m) |
| 2025-06-30 | $69.89M | $40.54M | $11.53M | $-123.27M | (m) | 172.41% | 28.45% | (m) | (m) |
| 2025-03-31 | $76.44M | $48.83M | $12.96M | $-113.83M | (m) | 156.54% | 26.54% | (m) | (m) |
| 2024-12-31 | $77.01M | $49.59M | $13.21M | $-108.93M | (m) | 155.28% | 26.63% | (m) | (m) |
| 2024-09-30 | $76.85M | $58.02M | $13.01M | $-100.56M | (m) | 132.44% | 22.41% | (m) | (m) |
| 2024-06-30 | $71.49M | $67.69M | $12.71M | $-92.20M | (m) | 105.62% | 18.78% | (m) | (m) |
| 2024-03-31 | $68.92M | $63.23M | $14.22M | $-100.01M | (m) | 109.00% | 22.49% | (m) | (m) |
| 2023-12-31 | $68.14M | $62.63M | $15.20M | $-106.38M | (m) | 108.80% | 24.27% | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | $-38.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | $-34.04M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | $-22.54M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $-6.49M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AEMETIS, INC (AMTX) | United States | $0.128B | -1.95 |
| TOMI Environmental Solutions, Inc. (TOMZ) | United States | $0.012B | |
| CODEXIS, INC. (CDXS) | United States | $0.151B | -6.68 |
| XCF Global, Inc. (SAFX) | United States | $0.171B | -2.86 |
| Comstock Inc. (LODE) | United States | $0.195B | -5.19 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |
| Alto Ingredients, Inc. (ALTO) | United States | $0.289B | 8.52 |
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| Westlake Chemical Partners LP (WLKP) | United States | $0.754B | 2.35 |
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |